ANNOVIANT Trademark

Trademark Overview


On Friday, April 23, 2021, a trademark application was filed for ANNOVIANT with the United States Patent and Trademark Office. The USPTO has given the ANNOVIANT trademark a serial number of 90668173. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 16, 2024. This trademark is owned by Annoviant, LLC. The ANNOVIANT trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Media for use in the augmentation of bone and tissue for medical purposes; Biological preparations for the treatment of cardiovascular, cardiopulmonary, musculoskeletal, diseases and disorders, and dermatological related diseases and disorders; Pharmaceutical preparations for the treatment of cardiovascular, cardiopulmonary, musculoskeletal, diseases and disorders, and dermatological related diseases and disorders; Pharmaceutical preparations and substances for the treatment and repair, reinforcement or buttressing of soft tissue and damaged skin; Pharmaceutical preparations for wounds; Pharmaceutical preparations and substances for use in soft tissue repair or the reconstruction of soft tissue deficiencies; Surgical tissues, namely, surgical implants comprising artificial material; Surgical implants comprising living tissue; Biological tissue made of or by living organic bone cells, skin cells, stem cells, epithelial cells, fat cells, nerve cells, muscle cells, and connective tissue c...

Artificial skin for surgical purposes; Synthetic media for use in the augmentation of bone and tissue for medical purposes; Artificial biomaterials for augmentation of bone and tissue for medical purposes; Medical devices and apparatus, namely, surgical implants comprised primarily of artificial material and also incorporating processed animal tissue for use in plastic reconstructive surgery, and repair, reinforcement or buttressing of soft tissue, and parts and fittings therefor; Surgical implants and mesh made of synthetic materials for use in soft tissue repair or the reconstruction of soft tissue deficiencies
annoviant

General Information


Serial Number90668173
Word MarkANNOVIANT
Filing DateFriday, April 23, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 21, 2022

Trademark Statements


Description of MarkThe mark consists of the word "Annoviant" with three waves starting from the bottom left corner of the "A" and continuing at a diagonal upwards to the middle portion of the opposite side of the "A". The three waves increase in length from bottom to top, with the bottommost wave being the shortest in length and the topmost wave being longest in length.
Goods and ServicesMedia for use in the augmentation of bone and tissue for medical purposes; Biological preparations for the treatment of cardiovascular, cardiopulmonary, musculoskeletal, diseases and disorders, and dermatological related diseases and disorders; Pharmaceutical preparations for the treatment of cardiovascular, cardiopulmonary, musculoskeletal, diseases and disorders, and dermatological related diseases and disorders; Pharmaceutical preparations and substances for the treatment and repair, reinforcement or buttressing of soft tissue and damaged skin; Pharmaceutical preparations for wounds; Pharmaceutical preparations and substances for use in soft tissue repair or the reconstruction of soft tissue deficiencies; Surgical tissues, namely, surgical implants comprising artificial material; Surgical implants comprising living tissue; Biological tissue made of or by living organic bone cells, skin cells, stem cells, epithelial cells, fat cells, nerve cells, muscle cells, and connective tissue cells intended for subsequent implantation; Biological implants, namely, a vital processed human or animal connective tissue; Biological tissue grafts; Vascular grafts; Medical adhesives for binding internal tissue
Goods and ServicesArtificial skin for surgical purposes; Synthetic media for use in the augmentation of bone and tissue for medical purposes; Artificial biomaterials for augmentation of bone and tissue for medical purposes; Medical devices and apparatus, namely, surgical implants comprised primarily of artificial material and also incorporating processed animal tissue for use in plastic reconstructive surgery, and repair, reinforcement or buttressing of soft tissue, and parts and fittings therefor; Surgical implants and mesh made of synthetic materials for use in soft tissue repair or the reconstruction of soft tissue deficiencies

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 30, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, July 30, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAnnoviant, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAlpharetta, GA 30022

Party NameAnnoviant, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAlpharetta, GA 30022

Trademark Events


Event DateEvent Description
Tuesday, April 27, 2021NEW APPLICATION ENTERED
Friday, July 30, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 17, 2021ASSIGNED TO EXAMINER
Saturday, July 31, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, December 20, 2021NON-FINAL ACTION WRITTEN
Monday, December 20, 2021NON-FINAL ACTION E-MAILED
Monday, December 20, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 2, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 2, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 2, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 11, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, May 11, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 11, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, May 11, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, May 11, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, May 11, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 11, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 17, 2022ASSIGNED TO LIE
Wednesday, May 18, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 1, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 21, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 16, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 21, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, January 23, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, July 26, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, July 26, 2023SOU EXTENSION 2 FILED
Wednesday, July 26, 2023SOU EXTENSION 2 GRANTED
Friday, February 16, 2024SOU TEAS EXTENSION RECEIVED
Friday, February 16, 2024SOU EXTENSION 3 FILED
Friday, February 16, 2024SOU EXTENSION 3 GRANTED
Monday, January 23, 2023SOU EXTENSION 1 FILED
Monday, January 23, 2023SOU EXTENSION 1 GRANTED
Wednesday, January 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 16, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, September 16, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Saturday, February 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED